Wag! Group (PET) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Nov, 2025Executive summary
Q1 2025 revenue was $15.2 million, down from $23.2 million in Q1 2024, reflecting a 34.7% year-over-year decline and a 30% drop in platform participants.
Net loss for Q1 2025 was $4.9 million, compared to $4.2 million in Q1 2024; adjusted EBITDA loss was $1.2 million versus positive $0.2 million last year.
Results were slightly ahead of internal profitability expectations due to disciplined cost management and operational efficiencies.
Early traction from new distribution partnerships and strong business trends noted through April and May.
The company is actively pursuing strategic alternatives, including refinancing, partnerships, or a sale, as debt matures in August 2025 and delisting from Nasdaq is pending.
Financial highlights
Q1 2025 revenue was $15.2 million, with an adjusted EBITDA loss of $1.2 million and net loss margin of (32.2%), both down from Q1 2024.
Services revenue: $4.9 million; wellness: $9.2 million; pet food and treats: $1.1 million.
Total costs and expenses decreased 25% year-over-year, down by over $6 million.
Net cash provided by operating activities was $1.4 million, up from $0.2 million in Q1 2024.
Cash and cash equivalents at quarter-end were $6.1 million, with $19.7 million in outstanding debt.
Outlook and guidance
Full-year 2025 revenue expected between $84 million and $88 million.
Full-year 2025 adjusted EBITDA forecasted in the range of $2 million to $4 million.
Management expects operating losses to continue as investments in business growth persist.
The company’s ability to continue as a going concern depends on successful refinancing, strategic transactions, or new financing before August 2025.
Board is reviewing strategic alternatives, but there is no assurance of a successful outcome before debt maturity.
Latest events from Wag! Group
- Record adjusted EBITDA and improved margins achieved, but liquidity and debt risks persist.PET
Q2 20242 Feb 2026 - Q3 revenue fell 39% with deepening losses, but Wellness rebounded and debt reduction continues.PET
Q3 202414 Jan 2026 - Q4 rebounded with 17%+ sequential growth; 2025 revenue guided at $84–$88 million.PET
Q4 202426 Dec 2025 - Chapter 11 filing, revenue drop, delisting, and asset sale mark a critical restructuring phase.PET
Q2 20257 Aug 2025